Literature DB >> 8074282

Detection of platelet aggregates with a particle counting method using light scattering.

Y Ozaki1, K Satoh, Y Yatomi, T Yamamoto, Y Shirasawa, S Kume.   

Abstract

A novel method to detect platelet aggregation by means of the particle counting technique using light scattering has been developed. An optical device designed to focus on a limited area of platelet-rich plasma measured the intensity of light scattered by particles passing through the area, minimizing multiple light scattering. The use of polystyrene spheres of different diameters confirmed that the light scattering intensity increases in proportion to the particle size in a suspension. Platelet activation induced by various agonists resulted in light scattering of higher intensities, which correlated well with the number and size of aggregates as observed under a microscope. These findings confirmed that the intensity of light scattering detected by the new device provides information on the number and size of aggregates in a suspension. The new method was compared with conventional platelet aggregometry using overall light scattering or changes in light transmission (optical density). The new device appeared to be particularly sensitive to small aggregates such as those formed in platelet activation induced by low concentrations of agonists. Furthermore, the new method has an advantage over the conventional aggregometry, in that it allows the aggregate size distribution and the extent of aggregation to be estimated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8074282     DOI: 10.1006/abio.1994.1180

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  19 in total

1.  Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects.

Authors:  Teddy Kosoglou; Larisa Reyderman; Renger G Tiessen; André A van Vliet; Robert R Fales; Robert Keller; Bo Yang; David L Cutler
Journal:  Eur J Clin Pharmacol       Date:  2011-09-21       Impact factor: 2.953

2.  Novel endotoxin assay by laser light-scattering particle-counting method.

Authors:  Kotaro Mitsumoto; Katsumi Yabusaki; Koji Kobayashi; Yoshiaki Shirasawa; Toru Obata
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

3.  Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates.

Authors:  H Matsuno; O Kozawa; S Nagashima; M Kanamaru; T Uematsu
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

4.  Platelet activation and aggregation during normothermic cardiopulmonary bypass.

Authors:  Y Misawa; H Konishi; K Kawahito; K Fuse
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-01

5.  Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures.

Authors:  Tomoko Komatsu; Yoshiko Tamai; Hideki Takami; Kazufumi Yamagata; Shinsaku Fukuda; Akihiro Munakata
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

6.  Is the size of an abdominal aortic aneurysm associated with coagulopathy?

Authors:  Shunya Shindo; Harunobu Matsumoto; Kenji Kubota; Atsuo Kojima; Masahiko Matsumoto; Kaneo Satoh; Yukio Ozaki
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

7.  Correlation between albuminuria and spontaneous platelet microaggregate formation in type 2 diabetic patients.

Authors:  Shin-ichi Araki; Hiroyuki Matsuno; Masakazu Haneda; Daisuke Koya; Yosuke Kanno; Junko Itho; Akio Kishi; Keiji Isshiki; Toshiro Sugimoto; Hiroshi Maegawa; Atsunori Kashiwagi; Takashi Uzu
Journal:  Diabetes Care       Date:  2009-08-12       Impact factor: 17.152

8.  Lack of alpha 2-antiplasmin enhances ADP induced platelet micro-aggregation through the presence of excess active plasmin in mice.

Authors:  Mariko Takei; Hiroyuki Matsuno; Kiyotaka Okada; Shigeru Ueshima; Osamu Matsuo; Osamu Kozawa
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

9.  Raloxifene enhances spontaneous microaggregation of platelets through upregulation of p44/p42 MAP kinase: a case report.

Authors:  H Tokuda; A Harada; S Adachi; R Matsushima-Nishiwaki; H Natsume; C Minamitani; J Mizutani; T Otsuka; O Kozawa
Journal:  Osteoporos Int       Date:  2009-04-07       Impact factor: 4.507

10.  The impact of platelet function or C-reactive protein, on cardiovascular events after an acute myocardial infarction.

Authors:  Angelo Modica; Fredrik Karlsson; Thomas Mooe
Journal:  Thromb J       Date:  2009-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.